MODIFIED T-CELLS FOR USE IN THE TREATMENT OF BLADDER CANCER
Application
US20260083849A1
Kind: A1
Mar 26, 2026
Inventors
Stephen DAWE, Alejandro GARCIA-CONSUEGRA LÓPEZ-PICAZO, José María SARO SUAREZ
Abstract
The disclosure relates to a method of treating bladder cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method.
CPC Classifications
A61K 40/4268
A61K 40/11
A61K 40/32
A61P 35/00
C07K 14/7051
C07K 16/30
Filing Date
2023-09-07
Application No.
19108853